Results 21 to 30 of about 699 (156)
Oliceridine for Analgesia in Elderly Patients Undergoing Kyphoplasty: From a Clinical Trial. [PDF]
Background As a G protein‐biased μ‐opioid receptor agonist, oliceridine can offer a relatively effective and safe analgesia. However, its effect on patients suffering from kyphoplasty was unexplored.
Miao C +5 more
europepmc +3 more sources
Assessment of the potential of novel and classical opioids to induce respiratory depression in mice
Abstract Background and Purpose Opioid‐induced respiratory depression limits the use of μ‐opioid receptor agonists in clinical settings and is the main cause of opioid overdose fatalities. The relative potential of different opioid agonists to induce respiratory depression at doses exceeding those producing analgesia is understudied despite its ...
Rob Hill +9 more
wiley +3 more sources
Neil Singla,1 Harold S Minkowitz,2 David G Soergel,3 David A Burt,3 Ruth Ann Subach,3 Monica Y Salamea,3 Michael J Fossler,3 Franck Skobieranda3 1Lotus Clinical Research, Pasadena, CA, 2Memorial Hermann Memorial City Medical Center, Houston, TX, 3Trevena,
Singla N +7 more
doaj +1 more source
Opioid analgesics such as morphine and fentanyl induce mu-opioid receptor (MOR)-mediated hyperactivity in mice. Herein, we show that morphine, fentanyl, SR-17018, and oliceridine have submaximal intrinsic efficacy in the mouse striatum using 35S-GTPγS ...
Agnes Acevedo-Canabal +7 more
doaj +2 more sources
Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults [PDF]
EditordOpioids used for the treatment of moderate to severe pain in an appropriate setting with appropriate management (stewardship) have good efficacy. However, when these are used long term their efficacy is questionable. Tolerance develops leading to escalating doses and a vicious circle of side-effects.
David Lambert, Girolamo Calo'
openaire +5 more sources
Opioid drug binding to specialized G protein-coupled receptors (GPCRs) can lead to analgesia upon activation via downstream Gi protein signaling and to severe side effects via activation of the β-arrestin signaling pathway. Knowledge of how different opioid drugs interact with receptors is essential, as it can inform and guide the design of safer ...
Thomas Giannos +5 more
openaire +5 more sources
Oliceridine and its potential to revolutionize GI endoscopy sedation
Providing sedation to patients undergoing gastrointestinal (GI) endoscopy is a controversial and emotive issue. The mainstay of sedation is propofol, whose administration is within the sole jurisdiction of anesthesia providers, at least in the USA. Attempts have been made to seize the authority by the GI community. One of the first attempts was the use
Goudra, Basavana, Singh, Preet Mohinder
openaire +6 more sources
Comparison of hemodynamic responses to endotracheal intubation with oliceridine and sufentanil during induction: a randomized controlled trial [PDF]
Background Oliceridine, a G-protein-biased μ-opioid receptor agonist, offers a potential alternative to conventional opioids by reducing adverse effects. However, its efficacy in attenuating the hemodynamic response to endotracheal intubation compared to
Yu Zhang +8 more
doaj +2 more sources
Effect of oliceridine on hypoxia during sedated hysteroscopy: a Phase 4 randomized clinical trial [PDF]
Background Hypoxia is a common complication in hysteroscopic surgery under sedation with conventional opioids. Oliceridine, a novel G protein-biased μ-opioid receptor agonist, provides effective analgesia with fewer opioid-related adverse events, but its
Ye Liu +9 more
doaj +2 more sources
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine [PDF]
AbstractOliceridine is a G protein–biased ligand at the μ‐opioid receptor in development for treatment of moderate to severe acute pain. A phase 1, open‐label, single‐dose study investigated the pharmacokinetics and safety of oliceridine 0.5 mg intravenous (IV) in subjects with end‐stage renal disease (ESRD, n = 9) versus 1 mg in healthy controls (n ...
Nafziger, Anne N. +5 more
openaire +3 more sources

